Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Polydipsia)
3,026 results
  • [New Diagnostic Standard in Diabetes Insipidus]. [Journal Article]
  • DMDtsch Med Wochenschr 2018; 143(24):1739-1744
  • Chifu I, Fenske W
  • 2018 brings new insights into the differential diagnosis of patients with hypotonic polyuria syndrome. Exact localization of the antidiuretic defect in patients with hypotonic polyuria can be challen...
  • Nephrogenic Diabetes Insipidus. [Review]
  • PCPediatr Clin North Am 2019; 66(1):227-234
  • Kavanagh C, Uy NS
  • Nephrogenic diabetes insipidus (NDI) results from the inability of the late distal tubules and collecting ducts to respond to vasopressin. The lack of ability to concentrate urine results in polyuria...
  • Anti-PD-1 pembrolizumab induced autoimmune diabetes in Chinese patient: A case report. [Case Reports]
  • MMedicine (Baltimore) 2018; 97(45):e12907
  • Li S, Zhang Y, … Fang C
  • CONCLUSIONS: Autoimmune diabetes induced by anti-programmed cell death-1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) therapy is a rare, but life threatening immune-related side effect. Physicians should closely monitor diabetes-related indexes of patients who have been undergoing the treatment of anti-PD-1/PD-L1 therapy.
New Search Next